Literature DB >> 83481

Increased levels of a nerve-growth-factor cross-reacting protein in "central" neurofibromatosis.

R N Fabricant, G J Todaro, R Eldridge.   

Abstract

Nerve-growth factor (N.G.F.) from serum was assayed in 9 affected individuals from three kindreds with the trait "central neurofibromatosis". The hallmark of this disease is bilateral acoustic neuromas. Antigenic activity, as measured by radioimmunoassay, was significantly elevated. However, functional activity for N.G.F.; as measured by radioreceptor assay, was normal or low. This indicates that the central form of neurofibromatosis is characterised by high circulating N.G.F. levels which show low to normal function. These changes in N.G.F. differ from those in peripheral neurofibromatosis and suggest that the two hereditary conditions involve different alterations in N.G.F. synthesis and/or regulation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 83481     DOI: 10.1016/s0140-6736(79)90452-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  2 in total

1.  Nerve growth factor receptor immunoreactivity in human benign peripheral nerve sheath tumor.

Authors:  T Yasuda; G Sobue; T Mitsuma; A Takahashi; Y Hashizume
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  Multiple meningiomas diagnosed by computed tomography.

Authors:  F Federico; P D'Aprile; A Lorusso; M Belsanti; A Carella
Journal:  Ital J Neurol Sci       Date:  1984-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.